Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sever

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|April 15, 2003
ALLHAT: definitive answers or continuing uncertainty?Peter Sever,
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 5, 2004
The VALUE trial: a commentaryPeter Sever
BMJ (Clinical Research Ed.)|July 14, 2009
Is systolic blood pressure all that matters? YesPeter Sever
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 1, 2017
Will the recent hypertension trials change the guidelines?Peter Sever
The Lancet Regional Health. Europe|December 6, 2021
Nocebo affects after COVID-19 vaccinationProfessor Peter Sever
Journal of Hypertension|September 5, 2025
Blood pressure variability: a reviewSpoorthy Kulkarni, Peter Sever
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 25, 2020
Amiloride: A reviewQianhui Sun, Peter Sever
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|May 15, 2020
The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?Peter Sever, Sebastian L Johnston
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|December 25, 2015
CommentaryPeter Sever, Graham MacGregor, Michael Schachter
Lancet (London, England)|October 31, 2017
Concerns related to the nocebo effect - Authors' replyAjay Gupta, Tom Godec, Peter Sever
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|April 15, 2003
ALLHAT: definitive answers or continuing uncertainty?Peter Sever,
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 5, 2004
The VALUE trial: a commentaryPeter Sever
BMJ (Clinical Research Ed.)|July 14, 2009
Is systolic blood pressure all that matters? YesPeter Sever
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 1, 2017
Will the recent hypertension trials change the guidelines?Peter Sever
The Lancet Regional Health. Europe|December 6, 2021
Nocebo affects after COVID-19 vaccinationProfessor Peter Sever
Journal of Hypertension|September 5, 2025
Blood pressure variability: a reviewSpoorthy Kulkarni, Peter Sever
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 25, 2020
Amiloride: A reviewQianhui Sun, Peter Sever
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|May 15, 2020
The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?Peter Sever, Sebastian L Johnston
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|December 25, 2015
CommentaryPeter Sever, Graham MacGregor, Michael Schachter
Lancet (London, England)|October 31, 2017
Concerns related to the nocebo effect - Authors' replyAjay Gupta, Tom Godec, Peter Sever
Pageof 12